Saturday, May 10, 2025

Apple: Analysts Anticipate Q3 Revenues Of $73.3 Billion

Apple (NASDAQ: AAPL) will be reporting their fiscal third quarter on July 27th after market close. Analysts have a consensus $159.98 12-month price target on the company, via a total of 41 analysts, with 12 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 7 have hold ratings, and one has a strong sell on the company. The street high comes from Wedbush Securities with a $185 price target, and the lowest target sits at $125 from Wolfe Research.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $73.276 billion; this number has been revised upwards from $66.284 billion at the start of the year. The highest revenue estimate is $77.054 billion, while the lowest is $65.682 billion.

Onto EBITDA estimates, there are currently only 9 analysts who have third-quarter EBITDA estimates. The mean is currently $22.516 billion, with this number having been revised up from $18.4 billion at the start of the year. Street high is a $24.44 billion EBITDA estimate and the lowest is $18.868 billion.

Analysts estimate that quarterly earnings per share will come in at $1.01, with this number being revised up from $0.76 at the start of the year. Street high is currently $1.16 and the lowest estimate is $0.82 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Vireo Health: Canaccord Lowers Revenue Estimates, Reiterates Price Target

Vireo Health (CSE: VREO) reported its second-quarter financials’ on August 26th, indicating revenue for the...

Thursday, August 27, 2020, 05:30:27 PM

Valens Company Sees Canaccord Lower Price Target To $4.25

Last week, The Valens Company (TSX: VLNS) reported its second-quarter financial results. The company announced...

Friday, July 23, 2021, 01:41:00 PM

Canaccord: Ford’s Absence From Rivian-Mercedes Deal Is Telling

On September 8, Mercedes-Benz announced that they had signed a Memorandum of Understanding with Rivian...

Sunday, September 11, 2022, 11:12:00 AM

Alphabet: Analyst Consensus Points To Q2 Revenues Of $69.95 Billion

Alphabet (NASDAQ: GOOGL) will be reporting its second quarter financial results on July 26th after...

Monday, July 25, 2022, 03:03:00 PM

Teladoc: Mixed Results From Analysts Following Q4 Results

On February 24th, Teladoc Health (NYSE: TDOC) reported their full-year and fourth quarter results. Fourth...

Friday, February 26, 2021, 04:06:40 PM